CVE:CZO Ceapro (CZO) Stock Price, News & Analysis C$0.22 -0.03 (-11.76%) As of 05/31/2024 Add Compare Share Share Stock Analysis Stock Analysis About Ceapro Stock (CVE:CZO) Get Ceapro alerts:Sign Up Key Stats Today's RangeC$0.23▼C$0.2450-Day RangeC$0.23▼C$0.2352-Week RangeC$0.15▼C$0.54Volume5,850 shsAverage Volume50,562 shsMarket CapitalizationC$688.88 thousandP/E RatioN/ADividend Yield1.80%Price TargetN/AConsensus RatingN/A Company Overview Ceapro Inc., a biotechnology company, engages in the development and marketing of health and wellness products and technology relating to plant extracts in the United States, Germany, China, Canada, and internationally. The company is involved in the development of proprietary extraction technologies and the application of these technologies to the production, development, and commercialization of active ingredients, such as oat beta glucan and avenanthramides, which are derived from oats and other renewable plant resources for healthcare and cosmetic industries. It also offers natural active ingredients, including oat powder, oat oil, oat peptides, and lupin peptides to the personal care, cosmetic, medical, and animal health industries; anti-aging skincare products to the cosmeceutical industries; and veterinary therapeutic products, including an oat shampoo, an ear cleanser, and a dermal complex/conditioner. The company has a research collaboration with the Angiogenesis Foundation. The company was incorporated in 1997 and is headquartered in Edmonton, Canada. Read More Receive CZO Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Ceapro and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. CZO Stock News HeadlinesUniversal Music Restructuring Continues, East Coast Labels Unite via Republic Corps DivisionMarch 12, 2024 | nz.finance.yahoo.comA Complete Breakdown of Kate Middleton's Photoshop ControversyMarch 12, 2024 | nz.finance.yahoo.comBezos… DOOMEDA single FCC filing hints Elon Musk is planning his biggest project yet - bigger than Tesla, SpaceX, and X combined - aimed at the $25 trillion AI industry. James Altucher says the plan could cut Amazon out of the AI race and disrupt Blue Origin, with a key deadline landing September 25.September 4 at 1:00 AM | Paradigm Press (Ad)Canadian Investment Regulatory Organization Trade Resumption - CZODecember 14, 2023 | finance.yahoo.comAeterna Zentaris and Ceapro Announce Merger of Equals to Create a Diversified Biopharmaceutical CompanyDecember 14, 2023 | finance.yahoo.comCeapro Inc. Reports 2023 Third Quarter and Nine-Month Financial Results and Operational HighlightsNovember 29, 2023 | finance.yahoo.comPSA: Charlotte Tilbury's Mystery Box is back, and there's a huge surprise in storeNovember 27, 2023 | nz.finance.yahoo.comCeapro Inc. Initiates Phase 1-2a Study Assessing Its Flagship Product Avenanthramides for Potential Applications in Inflammation Based DiseasesNovember 27, 2023 | finance.yahoo.comSee More Headlines CZO Stock Analysis - Frequently Asked Questions How have CZO shares performed this year? Ceapro's stock was trading at C$0.23 at the start of the year. Since then, CZO stock has increased by 0.0% and is now trading at C$0.23. How do I buy shares of Ceapro? Shares of CZO stock and other Canadian stocks can be purchased through an online brokerage account. Popular online brokerages with access to the Canadian stock market include BMO InvestorLine, CIBC Investor's Edge, Desjardins Online Brokerage, HSBC InvestDirect, Laurentian Bank Discount Brokerage, National Bank Direct Brokerage, Qtrade Investor, Questrade, RBC Direct Investing, Scotia iTrade, TD Direct Investing, and Virtual Brokers. What other stocks do shareholders of Ceapro own? Based on aggregate information from My MarketBeat watchlists, some other companies that Ceapro investors own include Franco-Nevada (FNV), Facedrive (FDVRF), FLYHT Aerospace Solutions (FLY), Ackroo (AKR), Badger Daylighting (BAD), BeWhere (BEW) and BlueRush (BTV). Industry, Sector and Symbol Stock ExchangeCVE SectorHealthcare Industry Biotechnology Sub-IndustryBiotechnology Current SymbolCVE:CZO CIKN/A Webwww.ceapro.com Phone+1-780-4214555FaxN/AEmployeesN/AYear FoundedN/AProfitability EPS (Trailing Twelve Months)C($0.08) Trailing P/E RatioN/A Forward P/E Ratio5.63 P/E GrowthN/ANet Income-C$243.04 thousand Net Margins-48.89% Pretax MarginN/A Return on Equity-15.66% Return on Assets-11.30% Debt Debt-to-Equity Ratio8.07 Current Ratio8.54 Quick Ratio18.88 Sales & Book Value Annual SalesC$348.52 thousand Price / Sales1.98 Cash FlowC$0.06 per share Price / Cash Flow3.94 Book ValueC$0.36 per share Price / Book0.63Miscellaneous Outstanding Shares3,061,689Free FloatN/AMarket CapC$688.88 thousand OptionableNot Optionable Beta1.38 10 Best Stocks to Own - Summer 2026Enter your email address and we’ll send you MarketBeat’s list of ten stocks set to soar in Summer 2026, despite the threat of tariffs and what's happening in Iran. These ten stocks are incredibly resilient and are likely to thrive in any economic environment. Get This Free Report This page (CVE:CZO) was last updated on 9/4/2026 by MarketBeat.com Staff. From Our PartnersTrump’s “new Petrodollar” exposedTrump has reportedly secured control over 65 billion barrels across 17 Venezuelan oil fields, more than the en...Porter & Company | SponsoredMusk says UBI is coming. I say it's already here.Elon Musk says AI could make money irrelevant by 2036. One income program already exists today, funded not by ...Freedom Financial | SponsoredMajor Buy Alert Issued for September 30thKeith Kaplan has invested $17 million into his own AI research tools, building a platform now used by 180,000 ...TradeSmith | SponsoredMan Who Called SpaceX Rise Says Elon’s NEW Project is Even BiggerJames Altucher called the rise of Nvidia, Apple, and SpaceX years before the crowd. Now he says he has uncover...Paradigm Press | SponsoredHalf the market is standing on a trapdoorNearly half the value of the US stock market now sits in AI stocks - the most concentrated the market has been...Behind the Markets | SponsoredAnthropic’s confidential SEC filing — and the public ticker that holds itAnthropic filed confidentially for an IPO, and its annualized revenue run rate reportedly surged to $65 billio...The Oxford Club | SponsoredA New Approach to Retirement Income That Needs Less CapitalThe secret to retiring without a million-dollar nest egg. I'm talking about generating enough monthly inco...Investors Alley | SponsoredPass by August 7… or wait until 2027?I’m making my next major call for what could be one of crypto’s biggest catalysts: The CLARITY Act. The bil...Crypto 101 Media | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Ceapro Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Ceapro With A Colleague Link copied to clipboard. Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.